Professor, President & CEO Erica Ollmann Saphire, Ph.D., MBA, is a leader in infectious disease research and has dedicated her career to bringing scientists together to face the toughest health threats.
Our Focus Is Immunology
We believe that no other biomedical discipline has greater implications for human health than immunology. By unraveling the complexities of the immune system, LJI researchers are directly tackling an extraordinarily diverse array of diseases, such as asthma, cancer, CoVID-19, type 1 diabetes, Parkinson’s, and many others.
At La Jolla Institute for Immunology, every day, our discoveries move the world closer to Life Without Disease.
Center for Autoimmunity and Inflammation
Enabling our experts to take a deep dive into the complexity of the immune system.
Center for Cancer Immunotherapy
At the forefront of exploring new and sometimes unexpected avenues for novel immune-based cancer treatments.
Center for Vaccine Innovation
Conducting fundamental research on how the body reacts to vaccines and battles infections.
Center for Sex-based Differences in the Immune System
Uncovering sex-specific variables in immune responses to provide personalized treatments for disease.
Our Impact
Research Services
Technological innovation and scientific advances are intricately linked and that is why La Jolla Institute puts a big emphasis to provide a first-rate scientific infrastructure and easy access to the latest technology. LJI’s scientific core facilities provide faculty, researchers and students with access to an array of state-of-the-art equipment, technologies, training and expertise to support innovative research. The Institute’s small size allows LJI researchers to interact closely with highly trained experts working in the research support services and to quickly adjust technical applications to the requirements of individual labs.
Our research services include: Bioinformatics, Clinical Studies, Cryo-EM, Flow Cytometry, Histopathology, Immunometabolism, Microscopy & Histology, and Next Generation Sequencing.
For more information on accessing our core facilities, please contact our Core Facilities Administrator.
Latest News
LJI discovery paves the way for antivirals against Ebola virus and its deadly relatives
Scientists capture first look at key viral structure within infected host cells
T cells may offer some protection in an H5N1 ‘spillover’ scenario
New LJI research suggests many people already have T cells with the power to fight "highly pathogenic" avian influenza
LJI selected as member of ARPA-H Investor Catalyst Hub Spoke Network
LJI joins a nationwide network working to accelerate transformative health solutions
Support Life Without Disease
Give Now
Seminars
"Molecular Cell Shielding: A Therapeutic Platform Approach for Hematological Diseases"
Speaker: Lukas Jeker, MD, PhD - Research Group Leader in the Department of Biomedicine at the University of Basel, Switzerland
La Jolla Institute - Ishizaka Seminar Room
Speaker: Ben Smarr
La Jolla Institute - Ishizaka Seminar Room